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Abstract
Background/Objective
Pre-eclampsia or Eclampsia (PE or E) accounts for 25% of cases of maternal mortality
worldwide. There is some evidence of a link to dietary factors, but few studies have explored
this association in developing countries, where the majority of the burden falls. We exam-
ined the association between adequately diversified dietary intake, iron and folic acid sup-
plementation during pregnancy and symptoms suggestive of PE or E in Indian women.
Methods
Cross-sectional data from India’s third National Family Health Survey (NFHS-3, 2005-06)
was used for this study. Self-reported symptoms suggestive of PE or E during pregnancy
were obtained from 39,657 women aged 15-49 years who had had a live birth in the five
years preceding the survey. Multivariable logistic regression analysis was used to estimate
the association between adequately diversified dietary intake, iron and folic acid supple-
mentation during pregnancy and symptoms suggestive of PE or E after adjusting for mater-
nal, health and lifestyle factors, and socio-demographic characteristics of the mother.
Results
In their most recent pregnancy, 1.2% (n=456) of the study sample experienced symptoms
suggestive of PE or E. Mothers who consumed an adequately diversified diet were 34%
less likely (OR: 0.66; 95% CI: 0.51-0.87) to report PE or E symptoms than mothers with in-
adequately diversified dietary intake. The likelihood of reporting PE or E symptoms was
also 36% lower (OR: 0.64; 95% CI: 0.47-0.88) among those mothers who consumed iron
and folic acid supplementation for at least 90 days during their last pregnancy. As a sensitiv-
ity analysis, we stratified our models sequentially by education, wealth, antenatal care visits,
birth interval, and parity. Our results remained largely unchanged: both adequately
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diversified dietary intake and iron and folic acid supplementation during pregnancy were as-
sociated with a reduced occurrence of PE or E symptoms.
Conclusion
Having a adequately diversified dietary intake and iron and folic acid supplementation in
pregnancy was associated with a reduced occurrence of symptoms suggestive of PE or E
in Indian women.
Introduction
Pre-eclampsia is a pregnancy-induced hypertensive disorder characterized by high blood pres-
sure and proteinuria, i.e. elevated levels of protein in the urine (used to distinguish pre-
eclampsia from gestational hypertension), after the 20th week of pregnancy [1]. Eclampsia is
defined as the occurrence of generalized seizures/convulsions and/or unexplained coma during
pregnancy or the postpartum period in the absence of other neurologic conditions such as epi-
lepsy [2–3]. Pre-eclampsia or eclampsia (PE or E) is one of the leading causes of maternal and
fetal mortality and morbidity worldwide [4], and is associated with adverse pregnancy out-
comes including perinatal death, preterm birth, and intrauterine growth retardation [1,5].
Based largely on clinical data, the incidence of pre-eclampsia is between 2 and 10%, depending
on the population studied and definition of pre-eclampsia used [6]; clinical studies suggest that
the proportion of deliveries impacted by PE or E in Indian women ranges from as low as 0.9%
to as high as 7.7% of all deliveries [7–9]. However, these clinical studies are likely to suffer from
selection bias on the basis of severity of the condition, especially among populations with limit-
ed access to prenatal care, and therefore may underestimate the prevalence of the condition.
Precise country-specific population level estimates of PE or E prevalence are
largely unavailable.
Although the etiology of PE or E remains unclear, the role of maternal diet in the develop-
ment of PE or E has recently received increased attention [10–11]. Several studies indicate that
micronutrient deficiencies, such as magnesium, vitamins A and C, folic acid [12], and calcium
[13–15] may contribute to PE or E risk. The evidence of a beneficial effect of maternal iron sup-
plementation during pregnancy is particularly compelling [16]. As well, three large-scale co-
hort studies of the association between folic acid supplements containing multivitamins and
gestational hypertension, including PE [12, 15,17–18], all show a protective effect of folic acid
supplementation on pre-eclampsia. A recent large cohort study from Denmark [19] shows that
regular use of folic acid in pregnancy is related to a reduced risk of pre-eclampsia among nor-
mal-weight women. However, two recent studies in China [20] and Holland [21] fail to find an
effect of folic acid supplementation on pre-eclampsia or gestational hypertension. The links be-
tween micronutrient supplementation and PE or E have largely been assessed in clinical trials,
but there is an urgent need for research examining links between PE or E and adequately diver-
sified dietary intake during pregnancy more broadly, especially in light of research suggesting
that nutrients may be better-absorbed from food sources than from supplements [22].
Several epidemiologic studies indicate that consumption of fruits, vegetables, and dietary
fibre is associated with lower pre-eclampsia risk [23–26], possibly influencing pre-eclampsia
through intestinal anti-inflammatory mechanisms [27]. It is hypothesized that inadequate anti-
oxidant and folate intake may contribute to oxidative stress, thereby increasing the risk of pre-
eclampsia [28]. Dietary intake, then, may shape PE or E risk by influencing micronutrient and
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antioxidant levels. For example, lycopene, an antioxidant found in many red fruits and vegeta-
bles, has been associated with a reduced risk of PE or E [29]. Dietary diversity—i.e. regular con-
sumption of food items across a broad range of food groups—is widely recognized as a key
dimension of diet quality, reflecting access to a variety of foods and serving as a proxy for indi-
vidual nutrient adequacy [30]. There is ample evidence from developed countries showing that
dietary diversity is indeed strongly associated with nutrient adequacy. Unfortunately there is a
dearth of studies from developing countries, but the few available studies support an associa-
tion between dietary diversity and nutrient adequacy [31–33].
Associations between diversified dietary intake, micronutrients, and hypertensive disorders
are particularly relevant in India, where rates of malnutrition and micronutrient deficiencies
are high among pregnant women [34]. To our knowledge, there has not been any previous
large-scale population based study of the dietary risk factors for PE or E in Indian women.
Studies which have examined the links between diet and PE or E empirically have not been
conducted in high burden countries; nor have they employed appropriate multivariable mod-
els. Similarly, much research has focused on treatment of PE or E, but less is known about po-
tential preventive factors, particularly those associated with maternal behaviours during
pregnancy [35–36].
Identifying the link between an adequately diversified dietary intake and the risk of PE or E
may suggest an important point of intervention at both the peri-conceptional and gestational
stages particularly in a developing country such as India. In this study, as dietary diversity is a
key factor in ensuring an adequate micronutrient balance, we use the large-scale, cross-
sectional and nationally representative third National Family and Health Survey (NFHS-3)
data [37–38] to test the hypothesis that adequately diversified dietary intake and iron and folic
acid supplementation during pregnancy are inversely related to the risk of PE or E among
Indian women.
Methodology
Cross-sectional data from the most recent wave of the National Family Health Survey (NFHS-
3, 2005–2006), India’s Demographic and Health Survey (DHS), was used for this study. These
data are publicly available by request from DHS [37]. The survey was approved by the ethics
boards of the implementing agencies in the respective states of India and by the Indian govern-
ment [38]. Our analysis used secondary survey data which was completely anonymised prior
to access. As the data were anonymised by the DHS [37], no ethics board review was required.
Using a multistage randomised cluster design (response rate = 98%), NFHS-3 employed an in-
terviewer-administered questionnaire in the native language of the respondent to collect socio-
demographic and health information, resulting in a nationally representative probability
sample of 124,385 women aged 15–49 years. All states of India are represented in the sample
(except the Union Territories covering less than 1% of India’s population). Full details of the
survey have been published elsewhere [38].
To assess symptoms of PE or E, we restricted the sample to those women who had a live
birth in the five years preceding the survey. We further restricted our analyses to data pertain-
ing to the most recent birth, both to minimize recall bias and in order to draw on iron and folic
acid supplementation and antenatal care (ANC) measures, which were only available for only
the most recent pregnancy. This resulted in a final sample size of 39,657 participants.
Outcome Measure
To assess the occurrence of PE or E, we constructed a measure based on women’s self-reports
of symptoms during pregnancy. Specifically, mothers were asked: “During this pregnancy, did
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you have difficulty with your vision during daylight?”, “During this pregnancy, did you have
swelling of the legs, body or face?”, and “During this pregnancy, did you have convulsions not
from fever?” The response options were “Yes”, “No”, and “Don’t know”. Following the World
Health Organisations [39] and National Institute for Health and Care Excellence guidelines
[40], we created a dichotomous indicator of PE or E: Women who reported both difficulty with
vision during daylight and swelling of the legs, body, or face, were coded as having symptoms
suggestive of pre-eclampsia, whereas those who additionally reported experiencing convulsions
(not from fever) were coded as eclamptic. However, it was not possible to confirm clinical diag-
nosis of these symptoms. Data on blood pressure and proteinuria during pregnancy, which are
typical clinical diagnostic markers of pre-eclampsia [41], were not available in the NFHS-3.
Data on physician reported diagnosis of convulsions/seizures were also not available in the
NFHS-3 to verify a self-reported diagnosis.
Key Predictors
Dietary diversity is often used as a proxy for dietary intake, both because it is a straightforward
measure of nutrition, and also because the burden on respondents is relatively low [30]. The
WHO [42] has identified 8 broadly defined food groups (grains, roots and tubers; legumes and
nuts; dairy products; flesh foods; eggs; vitamin A-rich fruits and vegetables; and other fruits
and vegetables), and suggests that individuals should eat from at least four food groups daily in
order to achieve an adequately diversified dietary intake. Based onWHO criteria [42], we creat-
ed a dietary diversity score from women’s self-reported frequency (daily, weekly, occasionally,
or never) of their consumption of milk or curd, green leafy vegetables, other vegetables, fruits,
pulses and beans, eggs, fish, and chicken or meat. For each food category, consumption of at
least one food item from the category is worth 1 point; however, consumption of foods that fall
into multiple categories (such as eggs, which are categorized both as flesh foods and eggs) is
worth 2 points. A minimum of 4 points is necessary for an adequately diversified dietary intake
[42]. However, as the NFHS-3 data do not contain consumption data for some of the WHO-
defined categories (e.g. grains, roots and tubers), we have modified the score so that a dietary
diversity score greater than or equal to three was considered to be an adequately diversified die-
tary intake, and less than three was considered inadequate. Dietary diversity at the time of the
survey was taken as a proxy measure for dietary diversity during pregnancy.
The other main exposure variable used in our study was self-reported consumption of iron
and folic acid supplementation during pregnancy. For the most recent birth, NFHS-3 asked to
mothers “Were you given or did you buy any iron and folic acid tablets or syrup?” In addition,
the duration (in days) of iron and folic acid supplementation was recorded, and was catego-
rized based on proposed national guidelines andWHO guidelines [43]. As iron and folic acid
supplementation were included in the same question rather than as separate survey items, we
were not able to include them as independent predictors in our models. We created a dichoto-
mous indicator of iron and folic acid supplementation.
Control Variables
Given the unknown etiology of PE or E, it is possible that its onset is influenced by sociodemo-
graphic and health-related factors. In order to adjust for this, we controlled for three groups of
potential confounders.
Maternal Factors. Categorical measures of age (15–29, 30–39, and 40–49 years) and birth
interval (first child,<2 years, 2–3 years, 3 years or more) and a dichotomous indicator of preg-
nancy type (single, multiple) were included to control for the positive association between ma-
ternal age [44–45], short birth intervals, multiple births, and health risks during pregnancy. As
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pre-eclampsia and eclampsia risk has been found to be higher in nulliparous women [28, 46],
we included a categorical measure of parity (1, 2, 3, or 4 or more). To control for the possibility
that progression from gestational hypertension to pre-eclampsia may be increased by a prior
miscarriage [47], we created a dichotomous indicator of whether the respondent ever had an
induced or spontaneous abortion. As anemia during pregnancy has been linked to pre-
eclampsia [48], we followed CDC recommendations [49] to construct a categorical measure of
anemia level (not anemic, mildly anemic, moderately anemic, and severely anemic) adjusted
for current pregnancy status, living at high altitudes, and smoking behaviour. In India, more
than 80% of the pregnant women received iron and folic acid supplementation through antena-
tal care (ANC), and women were provided with information on proper nutrition and the signs
and symptoms of pre-eclampsia and eclampsia during their ANC visit (38). Given the impor-
tance of appropriate ANC for maternal and child health, we thus included two controls for
self-reported utilization of ANC: a categorical measure of the number of visits (none, 1–3, and
4 or more) and access to healthcare, measured by a categorical indicator of type of healthcare
facility used (public medical sector, NGO trust hospital or clinic, private medical sector, and
other sources).
Health and Lifestyle Factors. As dietary patterns are likely to be part of a broader health
lifestyle, which may itself have implications for PE or E risk, we included a group of covariates
to adjust for health and lifestyle factors. Studies have demonstrated that women with pre-
eclampsia have a higher rate of pre-gestational hypertension and overweight or obese body
mass index (BMI) [50]. Following this, we included a Asian Population standard [51–53] BMI
(kg/m2) measure, categorized as underweight (18.5 kg/m2), normal (18.5 to 22.9 kg/m2),
overweight (23.0 to 24.9 kg/m2), and obese (25.0 kg/m2). As change in BMI between preg-
nancies has been estimated to be over one-half a unit (median 0.7; IQR −0.3–1.7) [54], we as-
sumed that there is unlikely to be a marked change in category of BMI between the birth and
the time of the survey. We therefore used BMI at the time of the survey as a proxy for pre-
pregnancy BMI. While maternal cigarette smoking increases the risk of a number of pregnancy
complications, smoking has consistently been shown to reduce the risk of pre-eclampsia by ap-
proximately 30% in western studies [55–59]. In NFHS-3, participants were asked four yes/no
questions on current use of cigarettes, pipes, other local tobacco smoking products, and snuff,
chew, or other smokeless tobacco products. As a dichotomous measure of current tobacco use,
we classified women as smokers if the response was ‘yes’ to smoking cigarettes, pipes, or other
local smoking products. Women were classified as ‘smokeless tobacco users’ if the response
was ‘yes’ to the use of chew, snuff, or other local smokeless tobacco products currently. As sev-
eral studies have found a negative association between prenatal alcohol consumption and pre-
eclampsia [60–62], we constructed a dichotomous indicator of current alcohol use. Due to the
association between diabetes and maternal health, we also included dichotomous indicators of
self-reported diabetes. Several studies have shown that women with gestational diabetes melli-
tus have an increased risk of pre-eclampsia or gestational hypertension [63–64] and that insu-
lin resistance predates the development of pre-eclampsia, implying that insulin resistance may
play a role in its etiology [65–66]. The risk of pre-eclampsia also increases with increasing glu-
cose intolerance [64,67–68]. Some studies also suggest that asthmatics, particularly those who
are symptomatic during pregnancy, may be at a higher risk of developing pre-eclampsia [69].
We thus included a dichotomous indicator of self-reported asthma in the current analysis.
Sociodemographic Characteristics. In order to reduce the risk of unobserved homogenei-
ty in our models, we included a variety of socio-demographic controls. Religion was catego-
rized into Hindu, Muslim, Christian, Sikhs or other/missing (Buddhist, Jain, Jewish,
Zoroastrian etc.). Caste was categorized as scheduled caste, scheduled tribe, other backward
class (NFHS-3 classification; hereafter referred to as disadvantaged class), general, and other/
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missing [38]. We also included categorical indicators of maternal education (no education, pri-
mary, secondary, and higher) and occupation (professional/ technical/managerial, clerical/
sales, agricultural work, services, skilled and unskilled manual labour, and not working).
Household wealth was categorized into quintiles based on the standard DHS index of house-
hold assets [37–38]. Place of residence was defined as either urban or rural. To account for dif-
ferences in dietary preferences, food security subsidies, and other factors which may vary
regionally, geographic regions was classified into six zones: north, northeast, central, east, west
and south.
Statistical Analysis
All analyses were conducted using the SPSS statistical software package Version 19 (IBM SPSS
Statistics, Chicago, Illinois, USA). Standard descriptive statistics were calculated for all vari-
ables, including means and standard deviations. Differences in categorical variables were tested
using χ2 tests. We assessed the possibility of multicollinearity between the covariates by using a
correlation matrix of covariates. All pairwise Pearson correlation coefficients were less than
0.5, suggesting that multicollinearity is not a concern. We included NFHS-3 sampling weights
to account for the sample design and ensure the representativeness of the sample [38]. Fixed ef-
fects multivariable logistic regression models [70–71] were then used to estimate the associa-
tion between dietary diversity, iron and folic acid supplementation during pregnancy, and PE
or E.
Multivariable models were adjusted for the above described maternal factors, health and
lifestyle factors and socio-demographic characteristics of the mother. In the first logistic regres-
sion model, we examined the unadjusted association between dietary diversity, iron and folic
acid supplementation and PE or E symptoms independent of each other. In the second model,
we adjusted for maternal factors in order to assess how much of the variance in this association
was explained by maternal characteristics. In the third model, we added health lifestyle factors
to our model. In the fourth and final model, we added socio-demographic characteristics in
order to examine the association between dietary diversity, iron and folic acid supplementation
and PE or E symptoms controlling for all the confounders discussed above. Maternal marital
status was not included as part of the socio-demographic characteristics because the majority
(i.e., 98%) were married. We also tested for a variety of potential interactive effects, for any pos-
sible significant interactions. In particular, given that ANC visits may improve maternal health
outcomes both by direct treatment of health conditions and by providing women with dietary
advice and supplementation, we tested for an interaction between ANC visits with each of our
two key predictors. State fixed effects were included in all models, and standard errors were
clustered at the primary sampling unit.
It has been argued that logistic regression models should be used with a minimum of 10
events per predictor variable (EPV) [72–74]. In this etiological observational study, we are in-
terested in adjusting for a number of covariates. Simulation studies show that 16–24 events per
variable also produce stable effect estimates [75]. Given that our sample size is 39,657 partici-
pants, a conservative event rate of 50% is an acceptable ratio of events to non-events to adjust
for the large number of covariates [75].
Sensitivity analyses
Women with better socioeconomic resources may a) have a better understanding of their
symptoms, b) report their experiences differently when compared to women in lower wealth
and education groups, and c) have access to a better diet during pregnancy. To overcome po-
tential sources of information bias, particularly with regard to self-reported diet and health
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problems during pregnancy, we ran sensitivity analyses for level of education (higher than sec-
ondary) and household wealth (richest quintile). Given that the population of women attend-
ing ANC might be inherently different than those who do not, we also conducted a sensitivity
analysis on ANC visits, restricting the sample to only those women who attended ANC.
Women who were currently pregnant or who had given birth within 2 months of the survey
were not weighed, resulting in missing values on the BMI measure for currently or recently
pregnant women. Due to list wise deletion, these women were excluded from our full regres-
sion models. Given that pregnancy should in theory be randomly distributed in the sample, it
is unlikely that this sample restriction would bias our sample. However, to test for potential
bias, we created a variable to flag cases that were missing on BMI, and ran our fully adjusted
model including the flag variable, but without BMI as a covariate in order to retain these cases.
However, since BMI is an important covariate that could influence the effect estimate, we have
again re-estimated the models by adding an additional category to the existing BMI variable to
signify those who were missing on the measure.
We also repeated the analysis, restricting it to those women who had given birth up to 3
years prior to the survey and reported PE or E symptoms to examine the potential effects of re-
call bias. Short birth intervals are associated with adverse perinatal outcomes [76], but long in-
tervals, especially those longer than 5 years, are also independently associated with an
increased risk of pre-eclampsia [77]. In a final set of sensitivity analyses, we restricted the mod-
els to multiparous women (74% of the sample) who were not currently pregnant, and examined
the effect of the length of the birth interval and PE or E risk.
Results
Table 1 presents the characteristics of the study sample. Overall, 1.2% (n = 456) of mothers re-
ported symptoms suggestive of PE or E. One-third of the mothers (31.1%) consumed an ade-
quately diversified diet and one-fourth reported of taking iron and folic acid supplementation
for at least 90 days during their last pregnancy, though almost two-thirds (65%) reported tak-
ing an iron and folic acid supplement at some point during their pregnancy. One-fourth of the
mothers were at first parity, and 31% of the births were preceded by an interval of more than 3
years and 1% of the pregnancies were multiple births.
Approximately one-fifth (18.5%) of the mothers reported a spontaneous or induced abor-
tion. Malnutrition rates were high: almost one-fifth of the mothers were moderately or severely
anaemic, 31% were underweight while 22% were either overweight or obese. More than half
the mothers had four or more ANC visits during their last pregnancy and almost 70% had ac-
cess to the private medical sector to obtain their health care. Very few were current smokers
(1.5%) or alcohol drinkers (2.3%), while almost one in ten were smokeless tobacco users
(8.3%). Prevalence of diabetes (1.3%) and asthma (1.2%) were low. Most mothers (almost
three-fourth) were aged 15–29 years, and almost half (47.4%) had no education. A majority of
the mothers (four out of five) were identified as Hindu, and two-fifths belonged to a disadvan-
taged class. One in four mothers were agricultural worker while a very few (1.8%) worked in
the service sector. One fourth belonged to the household with poorest wealth. More than 70%
of the mothers were residing in rural areas and 28% were residents of Central India.
Table 2 provides the percentage distribution of PE or E cases and prevalence of symptoms
of PE or E according to selected characteristics. Of women reporting PE or E symptoms, more
than four-fifths reported of inadequately diversified dietary intake; half had consumed iron
and folic acid supplementation and 13% adhered to the recommended duration (90 days) of
IFA intake; two-fifths (41%) were four and higher order births; 39% had a birth interval of 3
years or more; 2.4% were multiple pregnancies; one-fourth had terminated pregnancies; almost
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Table 1. Characteristics of the study participants (n = 39,657), India 2005–06.
Selected characteristics Women age 15–49 years
Number %
Maternal factors
Pre-eclampsia or Eclampsia symptoms
No 39155 98.8
Yes 456 1.2
Dietary diversity
Inadequate 27275 68.9
Adequate 12337 31.1
Iron and folic acid supplementation
No 13646 34.6
Yes 25809 65.4
Missing cases 157 0.4
Duration of iron and folic acid supplementation
<90 days 29588 74.7
90 days 10024 25.3
Parity
1 10453 26.4
2 11370 28.7
3 6810 17.2
4 and above 11005 27.8
Preceding birth interval
First order birth 10546 26.6
Interval <2 years 7124 18.0
Interval 2-3 years 9538 24.1
Interval 3 years or more 12448 31.4
Type of pregnancy
Singleton 39298 99.1
Multiple 359 0.9
Terminated pregnancy
Never 32319 81.5
Ever 7338 18.5
Anaemia level
Not anaemic 14939 40.1
Mild 15082 40.4
Moderate 6616 17.7
Severe 652 1.7
Missing cases 2362 6.0
Number of ANC visits
No visit 9020 22.8
1-3 9696 24.5
4 or more 20895 52.8
Healthcare access
Public medical sector 11303 31.3
NGO Trust Hospital/Clinic 113 0.3
Private Medical Sector 24591 68.1
Other sources 119 0.3
(Continued)
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Table 1. (Continued)
Selected characteristics Women age 15–49 years
Number %
Missing cases 3486 8.8
Health and Lifestyle factors
Body Mass Index
Underweight (18.5 kg/m2) 11592 30.5
Normal (18.5-22.9 kg/m2) 20714 54.4
Overweight (23.0-24.9 kg/m2) 2770 7.3
Obese (25.0 kg/m2) 3226 14.7
Missing cases 1609 4.1
Smoking tobacco
No 39049 98.5
Yes 608 1.5
Smokeless tobacco use
No 36333 91.7
Yes 3278 8.3
Drinks alcohol
No 38735 97.7
Yes 911 2.3
Missing cases 11 0.0
Current medical conditions
Diabetes
No 39123 98.7
Yes 160 1.3
Missing cases 20 0.1
Asthma
No 39163 98.8
Yes 470 1.2
Missing cases 24 0.1
Socioeconomic and demographic factors
Age
15-29 y 29190 73.6
30-39 y 9421 23.8
40-49 y 1047 2.6
Education
No education 18783 47.4
Primary 5550 14.0
Secondary 12959 32.7
Higher 2365 6.0
Missing cases 1 0.0
Religion
Hindu 31280 78.9
Muslim 6482 16.3
Christian 814 2.1
Sikhs 514 1.3
Others 568 1.4
Caste/tribe
(Continued)
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half (46%) were mildly anemic; more than two-thirds (71%) had access to public medical sector
for healthcare needs; 3% were obese; 2% was smoking tobacco; 13% were smokeless tobacco
users; 5% drinks alcohol; 1.8% and 5% reported having diabetes or asthma respectively; two-
thirds were in the age group 15–29 years; two-thirds had no education; 80% were Hindus; 38%
belonged to disadvantaged class; half were not working; two-fifths belong to poorest wealth
quintile; a majority resides in rural area whereas two-fifths resides in central India.
Considering prevalence of PE or E, a higher proportion of women with inadequate dietary
diversity reported of PE or E symptoms (1.4%) than those women with adequately diversified
dietary intake (0.6%). A higher proportion of those who did not consume iron and folic acid
supplementation for at least 90 days also reported of high PE or E (1.3%) symptoms as com-
pared to those who took iron and folic acid supplements for 90 or more days (0.6%). Women
Table 1. (Continued)
Selected characteristics Women age 15–49 years
Number %
Scheduled caste 7945 20.1
Scheduled tribes 3742 9.5
Disadvantaged class 15878 40.2
General 10845 27.5
Missing caste 1089 2.8
Missing cases 158 0.4
Occupation
Not working 24710 62.4
Professional/technical/managerial 670 1.7
Clerical/Sales 566 1.4
Agricultural work 9950 25.1
Services 715 1.8
Skilled and unskilled-Mannual 2991 7.6
Missing cases 9 0.0
Wealth index
Poorest 9566 24.1
Poorer 8600 21.7
Middle 7769 19.6
Richer 7256 18.3
Richest 6466 16.3
Place of residence
Urban 10622 26.8
Rural 29035 73.2
Geographic Regions
North 5678 12.8
Northeast 1613 4.1
Central 11111 28.0
East 10042 25.3
West 5117 12.9
South 6696 16.9
Total 39657 100.0
Note: Number of women varies slightly for individual variables depending on the number of missing values
doi:10.1371/journal.pone.0119120.t001
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Table 2. Percentage distribution of Pre-eclampsia or eclampsia cases and self-reported prevalence of symptoms suggestive of Pre-eclampsia
or eclampsia according to selected characteristics, India 2005–06.
Variables Total Number of Pre-eclampsia
or Eclampsia cases
% Distribution of Pre-eclampsia
or Eclampsia cases
% Prevalence of Pre-
eclampsia or Eclampsia
Χ2 p
value
Diet and iron and folic acid
intake
<0.0001
Dietary diversity
In adequate 377 82.5 1.4
Adequate 80 17.5 0.6
Iron and folic acid
supplementation
<0.0001
No 217 47.7 1.6
Yes 238 52.3 0.9
Duration of iron and folic acid
supplementation
<0.0001
<90 days 398 87.3 1.3
90 days 58 12.7 0.6
Maternal factors
Parity <0.0001
1 85 18.6 0.8
2 103 22.6 0.9
3 81 17.8 1.2
4 and above 187 41.0 1.7
Preceding birth interval <0.0001
First order birth 85 18.6 0.8
Interval <2 years 88 19.3 1.2
Interval 2-3 years 104 22.8 1.1
Interval 3 years or more 179 39.3 1.4
Type of pregnancy 0.003
Singleton 446 97.6 1.1
Multiple 11 2.4 3.1
Terminated pregnancy 0.005
Never 350 76.8 1.1
Ever 106 23.2 1.4
Anemia level <0.0001
Not anaemic 129 29.6 0.9
Mild 200 45.9 1.3
Moderate 101 23.2 1.5
Severe 6 1.4 0.9
Number of ANC visits <0.0001
No visit 149 32.6 1.7
1-3 148 32.4 1.5
4 or more 160 35.0 0.8
Healthcare access 0.190
Public medical sector 124 28.8 1.1
NGO Trust Hospital/Clinic 3 0.7 2.7
Private Medical Sector 304 70.5 1.2
Other sources 0 0.0 0.0
Health and Lifestyle factors
Body Mass Index 0.001
(Continued)
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Table 2. (Continued)
Variables Total Number of Pre-eclampsia
or Eclampsia cases
% Distribution of Pre-eclampsia
or Eclampsia cases
% Prevalence of Pre-
eclampsia or Eclampsia
Χ2 p
value
Underweight (18.5 kg/m2) 183 50.3 1.3
Normal (18.5-22.9 kg/m2) 224 41.1 1.3
Overweight (23.0-24.9 kg/m2) 23 5.2 0.8
Obese (25.0 kg/m2) 15 3.4 0.5
Smoking Tobacco 0.164
No 446 97.8 1.1
Yes 10 2.2 1.7
Smokeless tobacco use <0.0001
No 397 87.1 1.1
Yes 59 12.9 1.8
Drinks Alcohol <0.0001
No 433 94.7 1.1
Yes 24 5.3 2.6
Current medical conditions
Diabetes 0.240
No 448 98.2 1.1
Yes 8 1.8 1.6
Asthma <0.0001
No 434 95.2 1.1
Yes 22 4.8 4.7
Socioeconomic and
demographic factors
Age 0.013
15-29 y 309 67.6 1.1
30-39 y 134 29.3 1.4
40-49 y 14 3.1 1.3
Education <0.0001
No education 294 64.5 1.6
Primary 66 14.5 1.2
Secondary 91 20.0 0.7
Higher 5 1.1 0.2
Religion 0.027
Hindu 362 79.6 1.2
Muslim 69 15.2 1.1
Christian 6 1.3 0.7
Sikhs 4 0.9 0.8
Others 14 3.1 2.5
Caste/tribe <0.0001
Scheduled caste 99 21.8 1.2
Scheduled tribes 84 18.5 2.2
Disadvantaged class 173 38.0 1.1
General 88 19.3 0.8
Missing caste 11 2.4 1.0
Occupation <0.0001
Not working 228 50.0 0.9
(Continued)
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with mild (1.3%) and moderate anaemia (1.5%) also reported higher symptoms of PE or E as
compared to those with no (0.9%) or severe (0.9%) anaemia. Compared to overweight (0.8%)
or obese (0.5%) women, those who were underweight (1.3%) and normal weight (1.3%) re-
ported higher proportion of PE or E symptoms.
Pregnancy and health risk factors were also significantly associated with PE or E symptoms,
with a higher proportion of women of parity 4 or higher (1.7%) reported higher PE or E symp-
toms than women of lower parity. First order births had the lowest proportion of PE or E
symptoms (0.8%), while women with a birth interval of 3 or more years experienced signifi-
cantly higher symptoms of PE or E (1.4%). Multiple births were also associated with higher
odds of PE or E symptoms (3.1%) compared to singleton births (1.1%), as were previously
aborted pregnancies (1.4%) compared to those with no previous spontaneous or induced abor-
tions (1.1%). A higher proportion of current smokeless tobacco users (1.8%), current alcohol
drinkers (2.6%), and current tobacco smokers (1.7%) also reported PE or E symptoms com-
pared to those who, respectively, do not currently use tobacco, drink, or smoke. Additionally,
asthmatics (4.7%) reported higher PE or E symptoms than non-asthmatics (1.1%).
Significant associations were also found between socio-demographic characteristics and PE
or E symptoms. A lower proportion of women aged 15–29 reported PE or E symptoms (1.1%)
compared to women aged 30–39 (1.4%) and 40–49 years (1.3%). However, a higher proportion
of women with no education (1.6%) reported PE or E symptoms compared to those with pri-
mary, secondary, or higher levels of education. Caste was also a significant correlate, with a
higher proportion of women reporting PE or E symptoms belonging to a scheduled tribe
Table 2. (Continued)
Variables Total Number of Pre-eclampsia
or Eclampsia cases
% Distribution of Pre-eclampsia
or Eclampsia cases
% Prevalence of Pre-
eclampsia or Eclampsia
Χ2 p
value
Professional/technical/
managerial
8 1.8 1.2
Clerical/Sales 3 0.7 0.5
Agricultural work 173 37.9 1.7
Services 71 1.5 1.0
Skilled and unskilled-Manual 37 8.1 1.2
Wealth index <0.0001
Poorest 187 41.1 2.0
Poorer 109 24.0 1.3
Middle 76 16.7 1.0
Richer 47 10.3 0.6
Richest 36 7.9 0.6
Place of residence <0.0001
Urban 65 14.2 0.6
Rural 392 85.8 1.4
Geographic Regions <0.0001
North 52 11.4 1.0
Northeast 22 4.8 1.4
Central 188 41.2 1.7
East 137 30.0 1.4
West 36 7.9 0.7
South 21 4.6 0.3
Total 456 100.0 1.2
doi:10.1371/journal.pone.0119120.t002
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(2.2%) than those in a scheduled caste (1.2%), disadvantaged class (1.1%) or general caste
(0.8%). Those in the poorest wealth quintile reported the highest PE or E symptoms (2.0%)
compared to those in the other four wealth quintiles, as did those in professional (1.2%) and
agricultural (1.7%) occupations. Rural residence was also associated with increased proportion
of women reporting a PE or E symptoms (1.4%) compared to urban residence (0.6%), and
women living in central (1.7%), northeast (1.4%) and eastern (1.4%) India reported higher PE
or E symptoms than those in other regions.
Table 3 shows results of multivariable logistic regression analyses of the association between
dietary diversity, iron and folic acid supplementation during pregnancy, and symptoms sugges-
tive of PE or E, in unadjusted, partially adjusted and fully adjusted models. In the unadjusted
analysis (Model 1), the likelihood of reporting PE or E symptoms was significantly lower
among women who had an adequately diversified dietary intake (OR: 0.52; 95% CI: 0.41–0.66)
than among those who did not have a diversified dietary intake. Similarly, women who took
iron and folic acid supplements for 90 or more days during pregnancy had a lower likelihood
of reporting PE or E symptoms (OR: 0.48; 95% CI: 0.36–0.64) than those who did not take iron
or folic acid supplements for the recommended 90 days. Controlling for the maternal factors
(in Model 2) slightly attenuated the inverse relationship between diversified dietary intake
(OR: 0.57; 95% CI: 0.44–0.73) and PE or E, as well as between intake of iron and folic acid sup-
plementation (OR: 0.61; 95% CI: 0.45–0.8) and PE or E symptoms. The inverse association be-
tween the effect of diversified dietary intake (OR: 0.56; 95% CI: 0.43–0.72), intake of iron and
folic acid supplementation (OR: 0.56; 95% CI: 0.42–0.75) and PE or E symptoms remained vir-
tually unchanged when health and lifestyle factors were additionally controlled for in Model 3.
The final model (Model 4) in Table 3 provides the fully adjusted model with maternal factors,
health and lifestyle factors, and socio-demographic characteristics included. Of the significant
predictors from the bi-variable associations, twin pregnancy, ever having an abortion, mild or
moderate anaemia, being asthmatic, occupation, wealth quintile, and caste remained signifi-
cant predictors of PE or E symptoms in the fully adjusted model (Model 4), while parity, birth
interval, BMI, alcohol and tobacco use, age, education, place of residence, and geographic
Table 3. Unadjusted and adjusted odds ratios (ORs) and 95% conﬁdence interval (95%CI) showing the association between adequately
diversiﬁed dietary intake, iron and folic acid supplementation and symptoms of pre-eclampsia or eclampsia,India, 2005–06.
Key predictors Model 1 Unadjusted Model 2 Adjusted Model 3 Adjusted Model 4 Adjusted
OR[95%CI] OR[95%CI] OR[95%CI] OR[95%CI]
Diet and iron and folic acid intake
Dietary diversity
Adequate 0.52[0.41–0.66] 0.57[0.44–0.73] 0.56[0.43–0.72] 0.66[0.51–0.87]
Inadequate R 1.00 1.00 1.00 1.00
P value <0.0001 <0.0001 <0.0001 0.003
Duration of iron and folic acid supplementation
90 days 0.48[0.36–0.64] 0.61[0.45–0.82] 0.56[0.42–0.75] 0.64[0.47–0.88]
<90 days R 1.00 1.00 1.00 1.00
P value <0.0001 0.001 <0.0001 0.006
R Indicates reference category; Sample size is 39,657
Model 1 unadjusted
Model 2 adjusted for maternal factors only
Model 3 adjusted for maternal factors, health and lifestyle factors and current medical conditions
Model 4 adjusted for maternal, health and lifestyle factors, current medical conditions and socio-demographic characteristics
doi:10.1371/journal.pone.0119120.t003
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region were no longer significant. Jointly controlling for all of these factors, the inverse associa-
tion between an adequately diversified dietary intake (OR: 0.66; 95% CI: 0.51–0.87), recom-
mended intake of iron and folic acid supplementation (OR: 0.64; 95% CI: 0.47–0.88) and PE or
E symptoms during pregnancy remains strong and statistically significant. We found no evi-
dence of an interaction effect between dietary diversity, iron and folic acid supplementation
and ANC utilization in the fully adjusted model.
Results of the sensitivity analysis
As a robustness check, we ran Models 1 through 4 restricting only to those cases with valid
data on the BMI measure. Results remained largely unchanged: diversified dietary intake (OR:
0.67; 95% CI: 0.54–0.85; p = 0.004) and intake of iron and folic acid supplementation (OR:
0.65; 95% CI: 0.48–0.89; p = 0.006) continued to be significant predictors of lower occurrence
of PE or E symptoms in Indian women (not shown on the table). We again re-estimated the
models with BMI split into 5 categories (underweight, normal, overweight, obese, and missing)
and could found no demonstrable change in the association. Among women in the highest ed-
ucation group, the likelihood of reporting symptoms of PE or E was lower among those with a
adequately diversified dietary intake (OR: 0.60; 95% CI: 0.39–0.78) and recommended intake
of iron and folic acid supplementation (OR: 0.68; 95% CI: 0.45–0.98) during pregnancy (not
shown on the table). Even after additional adjustment for ANC visits, intake of an adequately
diversified diet was associated with a 43% (OR: 0.57; 95% CI: 0.44–0.73) and iron and folic acid
supplementation was associated with a 41% reduction in the likelihood of PE or E (OR: 0.59;
95% CI: 0.49–0.80) symptoms. Restricting our analysis to those women who had given birth up
to 3 years prior to the survey and reported PE or E symptoms (1.4%), we found that the associ-
ation of adequately diversified dietary intake, iron and folic acid supplementation, and PE or E
symptoms was non-significant. However, the number of women in this restricted sample was
very small (n = 46), and as a result the models had limited statistical power. In a final set of sen-
sitivity analyses restricting the models to multiparous women we found that the significant in-
verse association between diversified dietary intake, intake of iron and folic acid
supplementation during pregnancy and symptoms of PE or E still remained.
Discussion
In this study, we examined the association between adequately diversified dietary intake, iron
and folic acid supplementation during pregnancy, and symptoms suggestive of PE or E in a
large, nationally representative sample of Indian women. Our main analyses provide empirical
evidence of an inverse association between an adequately diversified dietary intake, iron and
folic acid supplementation during pregnancy and occurrence of symptoms suggestive of PE or
E. This association remained significant after controlling for a wide range of socio-demograph-
ic, maternal, and health and lifestyle factors. Overall 1.2% of the study sample experienced
symptoms suggestive of PE or E in their most recent pregnancy. Mothers who had a adequately
diversified dietary intake during pregnancy were 34% less likely to report PE or E symptoms
than mothers with inadequately diversified dietary intake. The likelihood of reporting PE or E
symptoms was also 36% lower among those mothers who consumed iron and folic supplemen-
tation for at least 90 days during their last pregnancy. Results from the sensitivity analyses sug-
gests that among highly educated mothers, the likelihood of reporting symptoms of PE or E
was 40% lower among those with an adequately diversified dietary intake and recommended
intake of iron and folic acid supplementation during pregnancy. Even after additional adjust-
ment for ANC visits, intake of an adequately diversified diet and recommended intake of iron
and folic acid supplementation were associated with a significantly lower likelihood of
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reporting PE or E symptoms. Restricting our analysis to only multiparous women we found
that the significant, inverse association between diversified dietary intake, recommended
intake of iron and folic acid supplementation during pregnancy and symptoms of PE or E
remained significant.
There is a mounting evidence that nutrition plays an important role in preventing hyperten-
sive disorders [14–15, 78–81], and maternal nutritional status has long been hypothesized to
have a role in the pathophysiology of PE or E [10, 29, 80, 82–90], especially in developed coun-
tries. There is also a strong evidence from both animal and human studies to support the hy-
pothesized protective effect of micronutrients such as iron and folic acid on low PE or E risk
[12, 15, 17–19]. Our study supports previous research [91–97] by providing population-level
evidence from a developing country that iron and folic acid supplementation may reduce the
symptoms of PE or E in pregnancy. Use of the National Family Health Survey data also provid-
ed adequate sample size to study the dietary correlates of PE or E in a population-level study,
thus providing a unique opportunity for descriptive inferences about the social distribution
and patterning of PE or E risk among Indian women.
Limitations of the study
There are several limitations to our study. First, most variables in the analyses (with the excep-
tion of anthropometrics) were self-reported, including a symptomatic rather than clinical mea-
sure of PE or E; it is possible that self-reported data may suffer from recall bias. Although we
cannot rule out the possibility of misclassification within this context, it is unlikely that we
have missed severe PE or E cases due to the generally clear manifestation of symptoms in severe
cases. Second, due to the nature of the data, we could not identify the gestational onset of PE or
E; it is possible that nutritional factors may be particularly important during critical periods of
foetal development, which we are not able to assess in this study. Third, the role of folic acid in-
dependent of iron supplementation may be of interest. However, because iron and folic acid
were measured jointly rather than as separate supplements in NFHS-3, we were unable to dis-
entangle the effects of these two supplements. Similarly, information about other micronutrient
supplementation is unavailable in the NFHS-3; while our models control for a wide range of
health and sociodemographic factors, it is possible that other micronutrients, such as B12, may
also shape PE or E risk. Further research is needed at the population level to understand the in-
dependent effects of micronutrient supplementation. An additional concern regarding the self-
reported data is potential misreporting of dietary intake; this misreporting would most likely
be non-differential, and may attenuate the association between dietary diversity and PE or E
symptoms. Moreover, the broad categories of food intake in the NFHS-3 limits our ability to
assess the impact of particular food items, especially those associated with diabetes (such as
sugar) and other health conditions. An adequately diversified dietary intake was associated
with higher socioeconomic status in our study; higher socioeconomic status may be associated
with both better diets and regular health check-ups. However, the results of our sensitivity
analyses of models stratified by wealth, education, and ANC visits suggest that this bias
is limited.
In our sample, the prevalence of PE or E symptoms was quite low (1.2%) as compared to
other studies in India. In part, this low prevalence is likely reflects the fact that survey partici-
pants were selected from the general population rather than from the higher-risk populations
used in many clinical and epidemiological studies. Additionally, because we were unable to
confirm PE or E with a clinical diagnosis, we have used a particularly stringent measure, requir-
ing women to have experienced both difficulties with daytime vision and swelling of the face
and extremities during pregnancy. This more stringent definition may result in a conservative
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bias in our results, as some women who reported experiencing only one symptom (and thus
were coded as not experiencing PE or E here) may have been identified as pre-eclamptic via
clinical diagnosis.
Our study also showed the prevalence of PE or E was higher among women of higher parity,
lean women, current smokers, and the less-educated. While these findings are in contrast to
some of the existing literature conducted in developed countries, they are in keeping with other
work among Asian women [46,98–99]. Our fully adjusted multivariable analyses results also fit
with previous literature pointing to increased risk of PE or E symptoms for: multiple (rather
than in singleton) pregnancies [100–102]; current smokers [55–56,103]; mothers with a history
of spontaneous or induced abortion [104–105]; women with asthma [106–107] and diabetes
[63,108]; and those from disadvantaged socio-demographic groups [47,109]. Lower age and
parity were not found to be associated with pre-eclampsia in contrast to other studies [110–
111]. The disparity between our study and other studies could be due to the differences in the
population-based sample here compared to hospital-based samples elsewhere. Our finding that
current tobacco smoking is associated with significantly increased risk of pre-eclampsia is also
consistent with previous research [55,112] though an earlier systematic review analyzing the
pooled data from cohort and case-control studies showed a lower risk of pre-eclampsia associ-
ated with cigarette smoking during pregnancy [56,103]. However, information on smoking
and alcohol here referred to the current lifestyle of the respondent rather than behaviour dur-
ing pregnancy, which may explain why our study departs from previous findings. Our findings
concur with previous studies regarding risks of PE or E arising from medical conditions such
as asthma, ethnicity [113], socio-economic position [109], and history of miscarriage or termi-
nated pregnancy [104–105]. However, a minor limitation of the present study is the inability to
differentiate between spontaneous and induced abortion because of the lack of information on
this variable.
Adverse maternal and infant health outcomes often can be prevented by modifying mater-
nal behaviours [35]. Monitoring behavioural risk factors can provide direction for interven-
tions to improve the health of mothers and infants. The current study extends previous
research by assessing the role of dietary factors and intake of iron and folic acid supplementa-
tion in pregnancy in shaping the PE or E risk. Low or inadequate diversified diet is particular
problematic in low- and middle-income countries (LMICs) [114–115], where the diets contain
a disproportionate share of starchy staples (e.g. rice, maize, potatoes) and wheat, while intake
of animal-source foods (meat, fish, eggs and dairy) and fresh fruit and vegetables is often insuf-
ficient. In addition, certain staple foods, such as wheat, maize, and millet, can contain high lev-
els of anti-nutrients (e.g. phytates), which reduce the absorption of available micronutrients
[115]. Many of the important vitamins and minerals essential for a healthy diet are found in
greatest abundance in fruits and vegetables, legumes, and flesh foods. The recent dietary transi-
tion in developing countries [116] towards low-cost processed grains, oils, and sugar has led to
a reduced intake of micronutrients and a progressive loss of dietary diversity. As a large pro-
portion of Indian women subsist on iron-poor vegetarian diets [117], large-scale iron supple-
mentation and fortification of commonly consumed vegetarian foodstuffs constitutes a
feasible, culturally appropriate, and cost-effective strategy for reducing pregnancy induced PE
or E symptoms. However, iron and folic acid supplementation needs to be placed in the
broader context of maternal nutritional status in India.
With the target of the Millennium Development Goals and adherence to India’s Five Year
Plan for reproductive health in sight, PE or E should be identified as a priority area in reducing
maternal morbidity in India. Dietary diversity and nutritional adequacy in pregnancy represent
modifiable risk factors for PE or E, and should be considered as targets for prevention. Efforts
which exclusively target micronutrient supplementation may not be sufficient for reducing PE
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or E symptoms. Policies aiming to reduce the risk of hypertension in pregnancy should target
improving access to, and compliance with, the simple recommended therapy of iron and folic
acid supplementation and an adequately diversified dietary intake in tandem. However, as this
analysis has demonstrated, there may be a substantial socioeconomic gradient in health risk be-
haviour and access to preventive care. Programmatic interventions should focus particularly
on women with limited socioeconomic resources. For example, programs targeting food securi-
ty among low income groups in India, such as the Public Distribution System (PDS), could im-
prove maternal and child health and reduce the risk of PE or E by offering a more diversified
basket of subsidized food items.
Conclusions
Using nationally representative data on reproductive health among Indian women, our study
shows that having an adequately diversified dietary intake and iron and folic acid supplementa-
tion in pregnancy is associated with a reduced occurrence of symptoms suggestive of PE or E
in Indian women. This relationship persists when sociodemographic, health lifestyle, and ma-
ternal factors are taken into consideration. Because ANC is the main source of iron and folic
acid supplements and nutrition education during pregnancy, ensuring universal provision of
comprehensive ANC, emphasized in India’s Eleventh Five Year Plan (2007–2012) [118], is
vital for improving maternal nutrition and health in India. Further epidemiological research in
India with large-scale cohorts should focus on uncovering preventable causes of PE or E such
as diet and micronutrient supplementation during pregnancy, while public health practice and
policy should promote improved access to better food and nutrition and mandatory intake of
iron and folic acid supplementation during pregnancy among Indian mothers.
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